Aging is under the control of a small number of regulatory genes. Mice
genetically selected for high immune responses, in most cases, exhibi
t longer life span and lower lymphoma incidence than do mice selected
for low responses. The link between immunity and aging is further evid
enced by the age-related alterations of the immune system, mostly of t
he T-cell population, in terms of replacement of virgin by memory cell
s, accumulation of cells with signal transduction defects, and changes
in the profile of Th1 and Th2 type cytokines. Also, B cells exhibit i
ntrinsic defects, and natural killer (NK) cell activity is profoundly
depressed by aging. In vitro experiments indicate that IL-2, IFN-gamma
, and IL-4 production by mouse spleen cells changes with aging and may
be upregulated by recombinant cytokines. These findings suggest possi
ble cytokine interventions to prevent or treat age-related immune diso
rders, as they may affect the duration and the biological quality of l
ife.